As of May 30, 2026, Entrada Therapeutics's top three insider holders are Bros. Advisors Lp Baker (TenPercentOwner, 4.69Mn shares), Todd Foley (Director, 4.43Mn shares), Bioventures 2014, L.P. Mpm (TenPercentOwner, 4.38Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Holding Ltd Roche | - | 0 | 2,813,525 | 04 Nov, 2021 |
| Peter S Kim | - | 104,330 | 0 | 05 Jun, 2024 |
| Bros. Advisors Lp Baker | - | 0 | 4,691,392 | 24 Nov, 2025 |
| Group, Llc Redmile | - | 0 | 1,954,420 | 04 Nov, 2021 |
| Todd Foley | - | 0 | 4,425,784 | 04 Nov, 2021 |
| Bioventures 2014, L.P. Mpm | - | 0 | 4,381,062 | 12 Dec, 2024 |
| Dipal Doshi | Ceo | 526,014 | 0 | 03 Mar, 2026 |
| Kush Parmar | - | 0 | 2,963,066 | 18 Nov, 2025 |
| Ventures V, L.P. 5Am | - | 2,963,066 | 0 | 18 Nov, 2025 |
| Kory James Wentworth | Chief Financial Officer | 119,010 | 0 | 02 Apr, 2026 |
| Bioventures 2018, L.P. Mpm | - | 0 | 4,381,062 | 12 Dec, 2024 |
| Nerissa Kreher | Chief Medical Officer | 40,037 | 0 | 06 Sep, 2023 |
| Nathan J Dowden | President Coo | 198,588 | 0 | 11 Mar, 2026 |
| Natarajan Sethuraman | President, Research Develop. | 242,224 | 0 | 03 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Kory James Wentworth | Common Stock | D | 2,500 | $12.95 | 119,010 | D | S |
| 09 Mar, 2026 | Nathan J Dowden | Common Stock | D | 3,116 | $13.02 | 210,482 | D | S |
| 09 Mar, 2026 | Kory James Wentworth | Common Stock | D | 5,089 | $13.00 | 132,898 | D | S |
| 10 Mar, 2026 | Nathan J Dowden | Common Stock | D | 11,894 | $13.05 | 198,588 | D | S |
| 10 Mar, 2026 | Kory James Wentworth | Common Stock | D | 11,388 | $13.02 | 121,510 | D | S |
| 04 Mar, 2026 | Kory James Wentworth | Common Stock | D | 7,988 | $12.25 | 137,987 | D | S |
| 01 Mar, 2026 | Natarajan Sethuraman | Common Stock | A | 55,800 | $0.00 | 253,699 | D | A |
| 01 Mar, 2026 | Dipal Doshi | Common Stock | A | 139,400 | $0.00 | 555,064 | D | A |
| 01 Mar, 2026 | Kory James Wentworth | Common Stock | A | 44,600 | $0.00 | 154,626 | D | A |
| 01 Mar, 2026 | Nathan J Dowden | Common Stock | A | 55,800 | $0.00 | 234,859 | D | A |
| 01 Mar, 2026 | Natarajan Sethuraman | Common Stock | A | 55,800 | $0.00 | 253,699 | D | A |
| 02 Mar, 2026 | Natarajan Sethuraman | Common Stock | D | 3,898 | $11.66 | 249,801 | D | F |
| 02 Mar, 2026 | Natarajan Sethuraman | Common Stock | D | 3,898 | $11.66 | 249,801 | D | F |
| 02 Mar, 2026 | Dipal Doshi | Common Stock | D | 9,869 | $11.66 | 545,195 | D | F |
| 02 Mar, 2026 | Nathan J Dowden | Common Stock | D | 7,223 | $11.66 | 227,636 | D | F |
| 02 Mar, 2026 | Kory James Wentworth | Common Stock | D | 2,939 | $11.66 | 151,687 | D | F |
| 03 Mar, 2026 | Dipal Doshi | Common Stock | D | 19,181 | $11.76 | 526,014 | D | F |
| 03 Mar, 2026 | Natarajan Sethuraman | Common Stock | D | 7,577 | $11.76 | 242,224 | D | F |
| 03 Mar, 2026 | Nathan J Dowden | Common Stock | D | 14,038 | $11.76 | 213,598 | D | F |
| 03 Mar, 2026 | Natarajan Sethuraman | Common Stock | D | 7,577 | $11.76 | 242,224 | D | F |